Dr. Ravi C. Vallabhan, MD

Dr. Vallabhan practices at Healthtexas Provider Network in Dallas, Texas.

Dr. Vallabhan's NPI, 1184672602, was assigned on May 5, 2006. Dr. Vallabhan graduated from Joe R. & Teresa Lozano Long School of Medicine in 1988. Dr. Vallabhan's Texas license number on file is H6673.

Dr. Vallabhan's primary practice is Healthtexas Provider Network, at 301 N Washington Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-3466.

Dr. Vallabhan's primary practice is Healthtexas Provider Network in Dallas, Texas. Dr. Vallabhan is also affiliated with Baylor University Medical Center. The medical group on file is HealthTexas Provider Network (HTPN). Dmand AI also links Dr. Vallabhan to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vallabhan practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Vallabhan's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Vallabhan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Vallabhan has a license on file in Texas.

Dmand AI lists angioplasty, cardiac catheterization and endocarditis among the conditions Dr. Vallabhan treats.

CMS data shows 7,282 Medicare services from Dr. Vallabhan across 27 procedure codes in 2024, for 758 Medicare patients. Medicare paid $243,614 for them.

CMS counts 758 Medicare patients who saw Dr. Vallabhan in 2024. The largest group is 65 to 74, with 308 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vallabhan's median patient age at 75, with 38% women.

In 2024, Dr. Vallabhan wrote 5,585 Medicare Part D claims for 730 patients. 80% of them were for generic drugs. CMS names the drug for 5,345 of them, across 50 drugs with 11 or more claims each, at $1,007,689 in total drug cost. In 2023, CMS named 5,036 claims across 51 drugs.

Dr. Vallabhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vallabhan as offering telehealth. CMS counts 61 procedures of coronary angioplasty and stenting by Dr. Vallabhan, more than 89% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Vallabhan, published from 2007 to 2025. 2017 was the busiest year, with 2. The most frequent topics are Percutaneous Coronary Intervention, Cardiac Catheterization and Heart Septal Defects, Atrial. Dr. Vallabhan has published most often in Am J Cardiol. Dr. Vallabhan's most frequent co-authors are Jeffrey M. Schussler, MD, Azam Anwar, MD and Paul A. Grayburn, MD.

Dmand AI links Dr. Vallabhan to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Bicuspid Aortic Valve Disease, Mitral Valve Insufficiency and Aortic Valve Disease. Medtronic Cardiovascular sponsors the most, 2.

CMS Open Payments shows 667 general payments to Dr. Vallabhan from 38 drug and device companies from 2016 to 2025. Education speaker fees make up the largest share, 38% of the total. Medtronic Vascular, Inc. paid the most, $28,181.

Dmand AI lists 5 awards for Dr. Vallabhan, most recently Regional Top Doctor in 2014.

Dr. Vallabhan graduated from Joe R. & Teresa Lozano Long School of Medicine in 1988. Dr. Vallabhan is a member of ACC.

Dr. Vallabhan is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.